Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.

Introduction: This study investigates the association between high-level systemic immune-inflammatory index (SII) and cirrhosis progression in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD). Methodology: A total of 272 CHB patients with NAFLD treated at Jinc...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Xue, Zeyu Wang, Jianguo Li
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2025-02-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/19636
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187748384702464
author Bo Xue
Zeyu Wang
Jianguo Li
author_facet Bo Xue
Zeyu Wang
Jianguo Li
author_sort Bo Xue
collection DOAJ
description Introduction: This study investigates the association between high-level systemic immune-inflammatory index (SII) and cirrhosis progression in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD). Methodology: A total of 272 CHB patients with NAFLD treated at Jincheng General Hospital between January 2018 and January 2023 were included. The study endpoint was the development of cirrhosis. The optimal SII cut-off value for predicting cirrhosis progression was determined as 1024 using ROC curve analysis and Youden index. Based on this cut-off, patients were classified into low SII (n = 159) and high SII (n = 113) groups. Univariate and multivariate Cox regression analyses were performed to identify independent predictors of cirrhosis progression and assess the relationship with SII. Results: Univariate Cox analysis revealed that SII was a significant risk factor for cirrhosis progression in CHB with NAFLD (HR = 2.062, 95% CI: 1.717-3.941, p < 0.001). Multivariate Cox regression analysis demonstrated a significant association between elevated SII levels and increased incidence of cirrhosis, with patients in the high SII group having an 88.5% higher risk (HR = 1.885, 95% CI: 1.167-3.045, p = 0.010). Kaplan-Meier survival analysis further confirmed the higher risk of cirrhosis in patients with high SII levels (log-rank p < 0.001) within 60 months. Conclusions: This study suggests that SII is a relevant risk factor for cirrhosis development in CHB individuals with NAFLD, emphasizing the importance of considering SII in current clinical management.
format Article
id doaj-art-ebf1c439d2d04387a4422ac4ca4dfd7d
institution OA Journals
issn 1972-2680
language English
publishDate 2025-02-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-ebf1c439d2d04387a4422ac4ca4dfd7d2025-08-20T02:16:02ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802025-02-01190210.3855/jidc.19636Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.Bo Xue0Zeyu Wang1Jianguo Li2Shanxi Medical University, Taiyuan, Shanxi Province, ChinaFuwai Hospital Chinese Academy of Medical Sciences, Bei Jing, ChinaShanxi Medical University, Taiyuan, Shanxi Province, China Introduction: This study investigates the association between high-level systemic immune-inflammatory index (SII) and cirrhosis progression in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD). Methodology: A total of 272 CHB patients with NAFLD treated at Jincheng General Hospital between January 2018 and January 2023 were included. The study endpoint was the development of cirrhosis. The optimal SII cut-off value for predicting cirrhosis progression was determined as 1024 using ROC curve analysis and Youden index. Based on this cut-off, patients were classified into low SII (n = 159) and high SII (n = 113) groups. Univariate and multivariate Cox regression analyses were performed to identify independent predictors of cirrhosis progression and assess the relationship with SII. Results: Univariate Cox analysis revealed that SII was a significant risk factor for cirrhosis progression in CHB with NAFLD (HR = 2.062, 95% CI: 1.717-3.941, p < 0.001). Multivariate Cox regression analysis demonstrated a significant association between elevated SII levels and increased incidence of cirrhosis, with patients in the high SII group having an 88.5% higher risk (HR = 1.885, 95% CI: 1.167-3.045, p = 0.010). Kaplan-Meier survival analysis further confirmed the higher risk of cirrhosis in patients with high SII levels (log-rank p < 0.001) within 60 months. Conclusions: This study suggests that SII is a relevant risk factor for cirrhosis development in CHB individuals with NAFLD, emphasizing the importance of considering SII in current clinical management. https://jidc.org/index.php/journal/article/view/19636Chronic viral hepatitis Bnon-alcoholic fatty liver diseasesystemic immune-inflammatory indexcirrhosis
spellingShingle Bo Xue
Zeyu Wang
Jianguo Li
Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
Journal of Infection in Developing Countries
Chronic viral hepatitis B
non-alcoholic fatty liver disease
systemic immune-inflammatory index
cirrhosis
title Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
title_full Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
title_fullStr Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
title_full_unstemmed Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
title_short Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
title_sort systemic immune inflammation index as a prognostic marker for chronic hepatitis b with non alcoholic fatty liver disease
topic Chronic viral hepatitis B
non-alcoholic fatty liver disease
systemic immune-inflammatory index
cirrhosis
url https://jidc.org/index.php/journal/article/view/19636
work_keys_str_mv AT boxue systemicimmuneinflammationindexasaprognosticmarkerforchronichepatitisbwithnonalcoholicfattyliverdisease
AT zeyuwang systemicimmuneinflammationindexasaprognosticmarkerforchronichepatitisbwithnonalcoholicfattyliverdisease
AT jianguoli systemicimmuneinflammationindexasaprognosticmarkerforchronichepatitisbwithnonalcoholicfattyliverdisease